In contrast, other common potent HDACIs, such as as suberoylanilide hydroxamic acid (SAHA), suberoyl bis-hydroxamic acid (SBHA), trichostatin A (TSA), and valproic acid (VPA) do not increase FXN gene expression in cells from FRDA patients. This evidence concerns the gene FXN and Friedreich ataxia.